News

The agency is reviewing a possible interaction between Sanofi’s heart drug Multaq and the blood thinner Warfarin that could lead to an ‘increased anticoagulant effect’. Takeda’s diabetes drug

Lead researcher Janine Erler has said the study found Sprycel, already in use to treat other cancers, to reduce bowel cancer cell growth in the lab by blocking

The LabChip DS, an automated UV/Vis spectral analysis platform helps in analysing concentration levels of about 96 nucleic acid and protein samples within a few minutes. Trinean CEO

The tie up licenses Torlii Pharma for the development, marketing and distribution of Mitizax, ALK’s tablet which is indicated for the treatment of house dust allergy. As per

For the third quarter of 2010, the company’s operating loss was $4.99m, compared to $5.07m for the same period in 2009. Net loss was $3.04m, compared to $3.03m

The enhanced technology will provide a level of passive protection from needle stick injury and will be available with less price point because of the small number of

The study which was designed to compare the efficacy, safety and tolerability of Gattex to placebo, showed 20% reduction in weekly PN volume at Weeks 20 and 24,

The technology acquired from CTI uses peptides chosen for their capability to adhere to diseased tissue. By coating these peptides on the surfaces of therapeutic cells, CTI has

Each party will hold 50% of the shares of the new company, and be equally represented on its management board. Bayer Zydus Pharma, which will operate in key